Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 2;12(572):eabb1717.
doi: 10.1126/scitranslmed.abb1717.

Endosomal recycling reconciles the Alzheimer's disease paradox

Affiliations
Review

Endosomal recycling reconciles the Alzheimer's disease paradox

Scott A Small et al. Sci Transl Med. .

Abstract

A hub-and-spoke model with endosomal recycling as the hub can reconcile the pathogenic contribution of amyloid precursor protein to Alzheimer's disease.

PubMed Disclaimer

Figures

FIGURE
FIGURE. A proposed ‘hub & spoke’ model for Alzheimer’s disease pathogenesis
Causal genes in early-onset Alzheimer’s disease affect the intracellular processing of the amyloid-precursor protein, while putative causal genes in late-onset disease affect intracellular trafficking. Both classes of genes converge by causing defects in endosomal recycling, a pathogenic event that occurs independent of amyloid. Endosomal recycling defects cause enlarged endosomes, a ‘traffic jam’ phenotype that is a hallmark cytopathology of the disease. Endosomal recycling defects can, through parallel pathways, trigger all four of the disease’s histopathological hallmarks: extracellular and intracellular amyloid pathology, tau pathology, synaptic pathology, and microglia pathology. Like the spokes of a wheel, the downstream pathologies might interconnect, but according to the model they represent the disease’s smoke, not its fire.

References

    1. Sato C et al., Tau Kinetics in Neurons and the Human Central Nervous System. Neuron 98, 861–864 (2018). - PMC - PubMed
    1. Katsinelos T et al., Unconventional Secretion Mediates the Trans-cellular Spreading of Tau. Cell Rep 23, 2039–2055 (2018). - PubMed
    1. Egan MF et al., Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease. N Engl J Med 380, 1408–1420 (2019). - PMC - PubMed
    1. Nicoll JAR et al., Persistent neuropathological effects 14 years following amyloid-beta immunization in Alzheimer’s disease. Brain 142, 2113–2126 (2019). - PMC - PubMed
    1. Holstege H et al., Characterization of pathogenic SORL1 genetic variants for association with Alzheimer’s disease: a clinical interpretation strategy. Eur J Hum Genet 25, 973–981 (2017). - PMC - PubMed

Substances

LinkOut - more resources